Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOVAXIM: Shanchol OCV Immunogenicity in Zambia
NCT04423159Completed
- Sponsor
- Center for Infectious Disease Research in Zambia
- Start
- Oct 2016
- Primary completion
- Oct 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of cholera vaccine (inactivated, oral) in cholera, sponsored by Center for Infectious Disease Research in Zambia. Primary endpoint: Vibriocidal antibody titers at 4 years. Started Oct 2016; status: completed.
02
Drugs
cholera vaccine (inactivated, oral)
03
Conditions
cholera
Beyond the preview
Go deeper on NCT04423159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04423159.